XML 1051 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Payment Arrangements (Tables)
12 Months Ended
Dec. 31, 2022
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
    
Fiscal Years
 
    
2022
    
2021
    
2020
 
Total cost of the Plans during the period
   $ 12,399      $ 27,537      $ 4,639  
Amount of related income tax benefit recognized during the period
     (5,199      (7,063      (2,114
    
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 7,200      $ 20,474      $ 2,525  
    
 
 
    
 
 
    
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
    
Number of
RSUs
    
Weighted Average

Grant Date

Fair Value
 
Outstanding at December 28, 2019
     198,875      $ 84.37  
Granted
     59,967      $ 102.58  
Shares earned in excess of target
(1)
     11,648      $ 77.00  
Vested shares, including shares earned in excess of target
     (76,290    $ 73.44  
Forfeited
     (10,987    $ 100.55  
    
 
 
          
Outstanding at December 26, 2020
     183,213      $ 93.44  
Granted
     46,342      $ 128.64  
Shares earned in excess of target
(2)
     7,132      $ 31.97  
Vested shares, including shares earned in excess of target
     (24,600    $ 59.85  
Forfeited
     (2,688    $ 107.76  
    
 
 
          
Outstanding at December 25, 2021
     209,399      $ 102.90  
Granted
     50,019      $ 139.44  
Shares earned in excess of target
(3)
     91,497      $ 92.58  
Vested shares, including shares earned in excess of target
     (177,146    $ 95.48  
Forfeited
     (21,989    $ 113.85  
    
 
 
          
Outstanding at December 31, 2022
     151,780      $ 115.80  
    
 
 
          
 
(1)
Represents additional shares earned under the February 2, 2017 RSU awards as fiscal year 2019 financial results exceeded target performance level.
(2)
Represents shares earned in excess of target under the May 1, 2015 RSU award as total shareholder return exceeded the target under the award.
(3)
Represents additional shares earned under each of the February 2, 2017, February 2, 2018 and February 1, 2019 RSU awards, as fiscal year 2021 financial results exceeded target performance level under each such award.
 
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
    
Number of

Shares and Deferred

Stock Units
    
Weighted Average
Grant Date

Fair Value
 
Non-vested
at December 28, 2019
     64,808      $ 98.24  
Granted
     26,604      $ 111.88  
Vested
     (28,621    $ 98.83  
Forfeited
     (2,351    $ 106.34  
    
 
 
          
Non-vested
at December 26, 2020
     60,440      $ 103.65  
Granted
     26,351      $ 150.20  
Vested
     (29,055    $ 104.35  
Forfeited
     (1,300    $ 97.81  
    
 
 
          
Non-vested
at December 25, 2021
     56,436      $ 125.16  
Granted
     25,354      $ 152.54  
Vested
     (27,074    $ 122.68  
Forfeited
     (6,921    $ 144.45  
    
 
 
          
Non-vested
at December 31, 2022
     47,795      $ 138.30  
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans:
 
    
Options Outstanding
    
Options Exercisable
 
    
Number of

Options
    
Weighted Average

Exercise Price

per Share
    
Number of

Options
    
Weighted Average

Exercise Price

per Share
 
Options at December 28, 2019
     44,467      $ 51.24        44,467      $ 51.24  
Exercised
     (26,817    $ 49.31                    
    
 
 
                            
Options at December 26, 2020
     17,650      $ 54.16        17,650      $ 54.16  
Exercised
     (9,080    $ 52.97                    
    
 
 
                            
Options at December 25, 2021
     8,570      $ 55.42        8,570      $ 55.42  
Exercised
     (6,670    $ 55.14                    
    
 
 
                            
Options at December 31, 2022
     1,900      $ 56.40        1,900      $ 56.40